Posttranscriptional gene expression regulation in CpG-activated macrophages depends on FXR1P RNA-binding protein

FEMS Immunology and Medical Microbiology

Volumn 51, Issue 2, 2007, Pages 422-430

  Lachance, Claude ^b   Thuraisingam, Thusanth ^b   Garnon, James ^b   Roter, Evan ^b   Radzioch, Danuta ^a,b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

CpG; Cytokines; FXR1P; Lipopolysaccharide; Macrophages; TNF

Indexed keywords

CHEMOKINE; CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; FXR1P PROTEIN; LIGAND; MESSENGER RNA; RESIQUIMOD; RNA BINDING PROTEIN; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; MACROPHAGE; MOLECULAR MECHANICS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RNA ANALYSIS; RNA STABILITY; STEADY STATE; TRANSCRIPTION REGULATION;

ANIMALS; CHEMOKINE CCL2; GENE EXPRESSION REGULATION; INTERLEUKIN-12; INTERLEUKIN-6; MACROPHAGES; MICE; MICE, KNOCKOUT; OLIGODEOXYRIBONUCLEOTIDES; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35148892615     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00317.x     Document Type: Article

References (48)

1. Akira S, Uematsu S Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124 : 783 801.
2. Anders HJ, Banas B, Linde Y, Weller L, Cohen CD, Kretzler M, Martin S, Vielhauer V, Schlondorff D Grone HJ (2003) Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors. J Am Soc Nephrol 14 : 317 326.
3. Beutler B Rietschel ET (2003) Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3 : 169 176.
4. Beutner KR, Spruance SL, Hougham AJ, Fox TL, Owens ML Douglas JM Jr. (1998) Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 38 : 230 239.
5. Blasi E, Back TC, Stull SW Varesio L (1987) Regulation of bone marrow cell survival in short-term cultures: a new macrophage function. Cell Immunol 104 : 334 342.
6. Buxade M, Ramirez-Alvarado M, Fernandez-Troy N, MacKenzie S, Casaroli-Marano RP, Vilella R Espel E (2001) Integrating signals from T-cell receptor and serum by T cells enhance translation of tumour necrosis factor-alpha. Immunology 102 : 416 425.
7. Cao Z, Xiong J, Takeuchi M, Kurama T Goeddel DV (1996) TRAF6 is a signal transducer for interleukin-1. Nature 383 : 443 446.
8. Carballo E, Lai WS Blackshear PJ (1998) Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281 : 1001 1005.
9. Chen CY Shyu AB (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20 : 465 470.
10. Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, Pruijn GJ, Stoecklin G, Moroni C, Mann M Karin M (2001) AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107 : 451 464.
11. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA Shlomchik MJ (2006) Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25 : 417 428.
12. Dean JL, Wait R, Mahtani KR, Sully G, Clark AR Saklatvala J (2001) The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol Cell Biol 21 : 721 730.
13. Di Marco S, Hel Z, Lachance C, Furneaux H Radzioch D (2001) Polymorphism in the 3′-untranslated region of TNFalpha mRNA impairs binding of the post-transcriptional regulatory protein HuR to TNFalpha mRNA. Nucleic Acids Res 29 : 863 871.
14. Fan XC Steitz JA (1998) Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 17 : 3448 3460.
15. Garnon J, Lachance C, Di Marco S, Hel Z, Marion D, Ruiz MC, Newkirk MM, Khandjian EW Radzioch D (2005) Fragile X-related protein FXR1P regulates proinflammatory cytokine tumor necrosis factor expression at the post-transcriptional level. J Biol Chem 280 : 5750 5763.
16. Goetz FW, Planas JV MacKenzie S (2004) Tumor necrosis factors. Dev Comp Immunol 28 : 487 497.
17. Gueydan C, Droogmans L, Chalon P, Huez G, Caput D Kruys V (1999) Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA. J Biol Chem 274 : 2322 2326.
18. Hochrein H, Schlatter B, O'Keeffe M, Wagner C, Schmitz F, Schiemann M, Bauer S, Suter M Wagner H (2004) Herpes simplex virus type-1 induces IFN-alpha production via toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci USA 101 : 11416 11421.
19. Karima R, Matsumoto S, Higashi H Matsushima K (1999) The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 5 : 123 132.
20. Kawai T Akira S (2006) TLR signaling. Cell Death Differ 13 : 816 825.
21. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D Kollias G (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 10 : 4025 4031.
22. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F Kollias G (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10 : 387 398.
23. Krieg AM (2006) Therapeutic potential of toll-like receptor 9 activation. Nat Rev Drug Discov 5 : 471 484.
24. Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT, Orihuela MM, Akira S, Yokoyama WM Colonna M (2004) TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21 : 107 119.
25. Lai WS, Carballo E, Strum JR, Kennington EA, Phillips RS Blackshear PJ (1999) Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 19 : 4311 4323.
26. Lund J, Sato A, Akira S, Medzhitov R Iwasaki A (2003) Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 198 : 513 520.
27. Mazan-Mamczarz K, Lal A, Martindale JL, Kawai T Gorospe M (2006) Translational repression by RNA-binding protein TIAR. Mol Cell Biol 26 : 2716 2727.
28. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S Janeway CA Jr. (1998) MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 2 : 253 258.
29. Mientjes EJ, Willemsen R, Kirkpatrick LL et al 2004) Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo. Hum Mol Genet 13 : 1291 1302.
30. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH Wagner H (1992) T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med 175 : 91 98.
31. Moisan J, Camateros P, Thuraisingam T et al 2006a) TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. Am J Physiol Lung Cell Mol Physiol 290 : L987 L995.
32. Moisan J, Thuraisingam T, Henault J, De SJ Radzioch D (2006b) Role of SLC11A1 (formerly NRAMP1) in regulation of signal transduction induced by Toll-like receptor 7 ligands. FEMS Immunol Med Microbiol 47 : 138 147.
33. Monick MM, Powers LS, Gross TJ, Flaherty DM, Barrett CW Hunninghake GW (2006) Active ERK contributes to protein translation by preventing JNK-dependent inhibition of protein phosphatase 1. J Immunol 177 : 1636 1645.
34. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z Matsumoto K (1999) The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398 : 252 256.
35. Peng SS, Chen CY, Xu N Shyu AB (1998) RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 17 : 3461 3470.
36. Piecyk M, Wax S, Beck AR et al 2000) TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J 19 : 4154 4163.
37. Raabe T, Bukrinsky M Currie RA (1998) Relative contribution of transcription and translation to the induction of tumor necrosis factor-alpha by lipopolysaccharide. J Biol Chem 273 : 974 980.
38. Roux PP Blenis J (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68 : 320 344.
39. Sabet M, Cottam HB Guiney DG (2006) Modulation of cytokine production and enhancement of cell viability by TLR7 and TLR9 ligands during anthrax infection of macrophages. FEMS Immunol Med Microbiol 47 : 369 379.
40. Shahbazian D, Roux PP, Mieulet V, Cohen MS, Raught B, Taunton J, Hershey JW, Blenis J, Pende M Sonenberg N (2006) The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J 25 : 2781 2791.
41. Syed TA, Ahmadpour OA, Ahmad SA Ahmad SH (1998) Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study. J Dermatol 25 : 429 433.
42. Tabeta K, Georgel P, Janssen E et al 2004) Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 101 : 3516 3521.
43. Takeda K, Kaisho T Akira S (2003) Toll-like receptors. Annu Rev Immunol 21 : 335 376.
44. Tracey KJ Cerami A (1994) Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 45 : 491 503, 491-503.
45. von Beust BR, Johansen P, Smith KA, Bot A, Storni T Kundig TM (2005) Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration. Eur J Immunol 35 : 1869 1876.
46. Wesche H, Henzel WJ, Shillinglaw W, Li S Cao Z (1997) MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7 : 837 847.
47. Wu JJ, Huang DB Tyring SK (2004) Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses. Antiviral Res 64 : 79 83.
48. Zhang W, Wagner BJ, Ehrenman K, Schaefer AW, DeMaria CT, Crater D, DeHaven K, Long L Brewer G (1993) Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol Cell Biol 13 : 7652 7665.